DE69120776T2 - Neue inhibitorische Peptide - Google Patents

Neue inhibitorische Peptide

Info

Publication number
DE69120776T2
DE69120776T2 DE69120776T DE69120776T DE69120776T2 DE 69120776 T2 DE69120776 T2 DE 69120776T2 DE 69120776 T DE69120776 T DE 69120776T DE 69120776 T DE69120776 T DE 69120776T DE 69120776 T2 DE69120776 T2 DE 69120776T2
Authority
DE
Germany
Prior art keywords
inhibitory peptides
new inhibitory
new
platelets
mediated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69120776T
Other languages
English (en)
Other versions
DE69120776D1 (de
Inventor
Samuel Andrew Santoro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Washington
Washington University in St Louis WUSTL
Original Assignee
University of Washington
Washington University in St Louis WUSTL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Washington, Washington University in St Louis WUSTL filed Critical University of Washington
Application granted granted Critical
Publication of DE69120776D1 publication Critical patent/DE69120776D1/de
Publication of DE69120776T2 publication Critical patent/DE69120776T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10Tetrapeptides
    • C07K5/1021Tetrapeptides with the first amino acid being acidic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69120776T 1990-10-25 1991-10-21 Neue inhibitorische Peptide Expired - Fee Related DE69120776T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/616,622 US5120830A (en) 1990-10-25 1990-10-25 Inhibitory peptides against α-2, β-1 mediated mg++ dependent adhesion of platelets to collagen

Publications (2)

Publication Number Publication Date
DE69120776D1 DE69120776D1 (de) 1996-08-14
DE69120776T2 true DE69120776T2 (de) 1997-01-16

Family

ID=24470287

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69120776T Expired - Fee Related DE69120776T2 (de) 1990-10-25 1991-10-21 Neue inhibitorische Peptide

Country Status (9)

Country Link
US (1) US5120830A (de)
EP (1) EP0488979B1 (de)
JP (1) JP3319771B2 (de)
AT (1) ATE140234T1 (de)
CA (1) CA2054111C (de)
DE (1) DE69120776T2 (de)
DK (1) DK0488979T3 (de)
ES (1) ES2089177T3 (de)
GR (1) GR3021064T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5594120A (en) 1994-02-18 1997-01-14 Brigham And Women's Hospital, Inc. Integrin alpha subunit
US5610281A (en) 1994-05-03 1997-03-11 Brigham & Women's Hospital, Inc. Antibodies for modulating heterotypic E-cadherin interactions with human T lymphocytes
US5962634A (en) * 1994-07-08 1999-10-05 Thomas Jefferson University IgE antagonists
US5932693A (en) * 1996-12-10 1999-08-03 Washington University Antithrombotic peptides
US20030176663A1 (en) * 1998-05-11 2003-09-18 Eidgenossische Technische Hochscule Specific binding molecules for scintigraphy
US6890896B1 (en) 1999-11-18 2005-05-10 Ceremedix, Inc. Compositions and methods for counteracting effects of reactive oxygen species and free radicals
WO2001062800A1 (en) * 2000-02-24 2001-08-30 Eidgenössische Technische Hochschule Zürich Antibody specific for the ed-b domain of fibronectin, conjugates comprising said antibody, and their use for the detection and treatment of angiogenesis
WO2002020563A2 (de) * 2000-09-07 2002-03-14 Schering Aktiengesellschaft REZEPTOR DER EDb-FIBRONEKTIN-DOMÄNE (II)
US8253725B2 (en) * 2007-12-28 2012-08-28 St. Jude Medical, Atrial Fibrillation Division, Inc. Method and system for generating surface models of geometric structures

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE123810T1 (de) * 1988-08-23 1995-06-15 Dana Farber Cancer Inst Inc Alpha-subeinheit des lfa-1-leukocyt-adhäsions- rezeptors.

Also Published As

Publication number Publication date
JP3319771B2 (ja) 2002-09-03
DK0488979T3 (da) 1996-08-12
EP0488979A1 (de) 1992-06-03
JPH0578389A (ja) 1993-03-30
CA2054111A1 (en) 1992-04-26
GR3021064T3 (en) 1996-12-31
ATE140234T1 (de) 1996-07-15
EP0488979B1 (de) 1996-07-10
DE69120776D1 (de) 1996-08-14
US5120830A (en) 1992-06-09
ES2089177T3 (es) 1996-10-01
CA2054111C (en) 2002-04-30

Similar Documents

Publication Publication Date Title
AU633913B2 (en) Novel tnf-inhibit proteins and their preparation
ES526201A0 (es) Un procedimiento para preparar un peptido que tiene influencia sobre la funcion de la glandula pituitaria
ATE491029T1 (de) Fibroblasten-wachstumsfaktoren-homologe
DE3875538D1 (de) Aminoluciferine, verfahren zu deren herstellung und ihre verwendung.
KR100295606B1 (de)
ATE140234T1 (de) Neue inhibitorische peptide
EP0979829A3 (de) Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an Oligopeptiden zur Hautaufhellung von Altersflecken bzw. zur Verhinderung der Hautbräunung, insbesondere der durch UV-Strahlung hervorgerufenen Hautbräunung
AU585167B2 (en) Novel substrate peptides
CO4340568A1 (es) Familia de peptidos con 51 aminoacidos en longitud, secuen- cias de definicion, la planta transgenica comprendida, el vector de expresion recombinante y el metodo para su pro- duccion.
GEP19981435B (en) Peptides with Organo-Protective Activity, Pharmaceutical Composition and the Use Thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee